Expression, function, and molecular properties of the killer receptor Ncr1-Noé

Journal of Immunology

Volumn 195, Issue 8, 2015, Pages 3959-3969

  Glasner, Ariella ^a   Simic, Hrvoje ^b   Miklić, Karmela ^b   Roth, Ziv ^c   Berhani, Orit ^a   Khalaila, Isam ^c   Jonjic, Stipan ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HELIOS PROTEIN; NATURAL CYTOTOXICITY RECEPTOR 1; RECEPTOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; IKAROS TRANSCRIPTION FACTOR; IKZF2 PROTEIN, HUMAN; LY ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1 PROTEIN, HUMAN; NCR1 PROTEIN, MOUSE; ZFPN1A2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; INFECTION CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; IMMUNOLOGY; MUTATION; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, LY; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; IKAROS TRANSCRIPTION FACTOR; MICE; MICE, TRANSGENIC; MUTATION; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; TRANSCRIPTION FACTORS;

EID: 84943557107     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501234     Document Type: Article

References (44)

1. Achdout, H., T. Meningher, S. Hirsh, A. Glasner, Y. Bar-On, C. Gur, A. Porgador, M. Mendelson, M. Mandelboim, and O. Mandelboim. 2010. Killing of avian and swine influenza virus by natural killer cells. J. Virol. 84:3993-4001.
2. Arnon, T. I., M. Lev, G. Katz, Y. Chernobrov, A. Porgador, and O. Mandelboim. 2001. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 31:2680-2689.
3. Chaushu, S., A. Wilensky, C. Gur, L. Shapira, M. Elboim, G. Halftek, D. Polak, H. Achdout, G. Bachrach, and O. Mandelboim. 2012. Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog. 8:e1002601.
4. Draghi, M., A. Pashine, B. Sanjanwala, K. Gendzekhadze, C. Cantoni, D. Cosman, A. Moretta, N. M. Valiante, and P. Parham. 2007. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J. Immunol. 178:2688-2698.
5. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7:517-523.
6. Glasner, A., H. Ghadially, C. Gur, N. Stanietsky, P. Tsukerman, J. Enk, and O. Mandelboim. 2012. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1. J. Immunol. 188:2509-2515.
7. Halfteck, G. G., M. Elboim, C. Gur, H. Achdout, H. Ghadially, and O. Mandelboim. 2009. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1. J. Immunol. 182:2221-2230.
8. Jarahian, M., M. Fiedler, A. Cohnen, D. Djandji, G. J. Hämmerling, C. Gati, A. Cerwenka, P. C. Turner, R. W. Moyer, C. Watzl, et al. 2011. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog. 7:e1002195.
9. Jarahian, M., C. Watzl, P. Fournier, A. Arnold, D. Djandji, S. Zahedi, A. Cerwenka, A. Paschen, V. Schirrmacher, and F. Momburg. 2009. Activation of natural killer cells by Newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 83:8108-8121.
10. Lakshmikanth, T., S. Burke, T. H. Ali, S. Kimpfler, F. Ursini, L. Ruggeri, M. Capanni, V. Umansky, A. Paschen, A. Sucker, et al. 2009. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J. Clin. Invest. 119:1251-1263.
11. Gur, C., Y. Ibrahim, B. Isaacson, R. Yamin, J. Abed, M. Gamliel, J. Enk, Y. Bar-On, N. Stanietsky-Kaynan, S. Coppenhagen-Glazer, et al. 2015. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42:344-355.
12. Seidel, E., V. T. Le, Y. Bar-On, P. Tsukerman, J. Enk, R. Yamin, N. Stein, D. Schmiedel, E. Oiknine Djian, Y. Weisblum, et al. 2015. Dynamic co-evolution of host and pathogen: HCMV downregulates the prevalent allele MICAp008 to escape elimination by NK cells. Cell Rep. 2015:S2211-1247 (15) 00054-6.
13. Kärre, K. 2002. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55:221-228.
14. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
15. Lankry, D., H. Simic, Y. Klieger, F. Levi-Schaffer, S. Jonjic, and O. Mandelboim. 2010. Expression and function of CD300 in NK cells. J. Immunol. 185:2877-2886.
16. Markel, G., H. Mussaffi, K. L. Ling, M. Salio, S. Gadola, G. Steuer, H. Blau, H. Achdout, M. De Miguel, T. Gonen-Gross, et al. 2004. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 103:1770-1778.
17. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
18. Stanietsky, N., H. Simic, J. Arapovic, A. Toporik, O. Levy, A. Novik, Z. Levine, M. Beiman, L. Dassa, H. Achdout, et al. 2009. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA 106:17858-17863.
19. Biassoni, R., A. Pessino, C. Bottino, D. Pende, L. Moretta, and A. Moretta. 1999. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 29:1014-1020.
20. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409:1055-1060.
21. Tsukerman, P., N. Stern-Ginossar, C. Gur, A. Glasner, D. Nachmani, Y. Bauman, R. Yamin, A. Vitenshtein, N. Stanietsky, T. Bar-Mag, et al. 2012. MiR-10b downregulates the stress-induced cell surface molecule MICB, a critical ligand for cancer cell recognition by natural killer cells. Cancer Res. 72:5463-5472.
22. Glasner, A., A. Zurunic, T. Meningher, T. Lenac Rovis, P. Tsukerman, Y. Bar-On, R. Yamin, A. F. Meyers, M. Mandeboim, S. Jonjic, and O. Mandelboim. 2012. Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One 7:e36837.
23. Gur, C., J. Enk, S. A. Kassem, Y. Suissa, J. Magenheim, M. Stolovich-Rain, T. Nir, H. Achdout, B. Glaser, J. Shapiro, et al. 2011. Recognition and killing of human and murine pancreatic β cells by the NK receptor NKp46. J. Immunol. 187:3096-3103.
24. Elboim, M., R. Gazit, C. Gur, H. Ghadially, G. Betser-Cohen, and O. Mandelboim. 2010. Tumor immunoediting by NKp46. J. Immunol. 184:5637-5644.
25. Bar-On, Y., A. Glasner, T. Meningher, H. Achdout, C. Gur, D. Lankry, A. Vitenshtein, A. F. Meyers, M. Mandelboim, and O. Mandelboim. 2013. Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell Reports 3:1044-1050.
26. Gur, C., A. Porgador, M. Elboim, R. Gazit, S. Mizrahi, N. Stern-Ginossar, H. Achdout, H. Ghadially, Y. Dor, T. Nir, et al. 2010. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat. Immunol. 11:121-128.
27. Wensveen, F. M., V. Jeleńcić, S. Valentić, M. ͆estan, T. T. Wensveen, S. Theurich, A. Glasner, D. Mendrila, D. ͆timac, F. T. Wunderlich, et al. 2015. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 16:376-385.
28. Gur, C., S. Doron, S. Kfir-Erenfeld, E. Horwitz, L. Abu-Tair, R. Safadi, and O. Mandelboim. 2012. NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 61:885-893.
29. Gur, C., S. Coppenhagen-Glazer, S. Rosenberg, R. Yamin, J. Enk, A. Glasner, Y. Bar-On, O. Fleissig, R. Naor, J. Abed, et al. 2013. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell Host Microbe 14:664-674.
30. Narni-Mancinelli, E., B. N. Jaeger, C. Bernat, A. Fenis, S. Kung, A. De Gassart, S. Mahmood, M. Gut, S. C. Heath, J. Estellé, et al. 2012. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science 335:344-348.
31. Sheppard, S., C. Triulzi, M. Ardolino, D. Serna, L. Zhang, D. H. Raulet, and N. Guerra. 2013. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood 121:5025-5033.
32. Achdout, H., T. I. Arnon, G. Markel, T. Gonen-Gross, G. Katz, N. Lieberman, R. Gazit, A. Joseph, E. Kedar, and O. Mandelboim. 2003. Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol. 171:915-923.
33. Roth, Z., S. Parnes, S. Wiel, A. Sagi, N. Zmora, J. S. Chung, and I. Khalaila. 2010. N-glycan moieties of the crustacean egg yolk protein and their glycosylation sites. Glycoconj. J. 27:159-169.
34. Babić, M., M. Pyzik, B. Zafirova, M. Mitrović, V. Butorac, L. L. Lanier, A. Krmpotić, S. M. Vidal, and S. Jonjić. 2010. Cytomegalovirus immunoevasin reveals the physiological role of "missing self" recognition in natural killer cell dependent virus control in vivo. J. Exp. Med. 207:2663-2673.
35. Bubić, I., M. Wagner, A. Krmpotić, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjić, and U. H. Koszinowski. 2004. Gain of virulence caused by loss of a gene in murine cytomegalovirus. J. Virol. 78:7536-7544.
36. Miletić, A., A. Krmpotić, and S. Jonjić. 2013. The evolutionary arms race between NK cells and viruses: who gets the short end of the stick? Eur. J. Immunol. 43:867-877.
37. Mitrović, M., J. Arapović, S. Jordan, N. Fodil-Cornu, S. Ebert, S. M. Vidal, A. Krmpotić, M. J. Reddehase, and S. Jonjić. 2012. The NK cell response to mouse cytomegalovirus infection affects the level and kinetics of the early CD8+ T-cell response. J. Virol. 86:2165-2175.
38. Arnon, T. I., H. Achdout, N. Lieberman, R. Gazit, T. Gonen-Gross, G. Katz, A. Bar-Ilan, N. Bloushtain, M. Lev, A. Joseph, et al. 2004. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103:664-672.
39. Moretta, L., and A. Moretta. 2004. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23:255-259.
40. Elias, S., R. Yamin, L. Golomb, P. Tsukerman, N. Stanietsky-Kaynan, D. Ben-Yehuda, and O. Mandelboim. 2014. Immune evasion by oncogenic proteins of acute myeloid leukemia. Blood 123:1535-1543.
41. Sata, T., J. Roth, C. Zuber, B. Stamm, and P. U. Heitz. 1991. Expression of alpha 2, 6-linked sialic acid residues in neoplastic but not in normal human colonic mucosa. A lectin-gold cytochemical study with Sambucus nigra and Maackia amurensis lectins. Am. J. Pathol. 139:1435-1448.
42. Koide, N., and T. Muramatsu. 1974. Endo-beta-N-acetylglucosaminidase acting on carbohydrate moieties of glycoproteins. Purification and properties of the enzyme from Diplococcus pneumoniae. J. Biol. Chem. 249:4897-4904.
43. 4-(N-acetyl-β-glucosaminyl) asparagine amidase A and its N-glycans. Eur. J. Biochem. 252:118-123.
44. Siewiera, J., H. El Costa, J. Tabiasco, A. Berrebi, G. Cartron, P. Le Bouteiller, and N. Jabrane-Ferrat. 2013. Human cytomegalovirus infection elicits new decidual natural killer cell effector functions. PLoS Pathog. 9:e1003257.